The Current Ratio as of December 2025 (TTM) for Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) is 0.82

According to Hainan Huluwa Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.82. This represents a change of -3.14% compared to the average of 0.85 of the last 4 quarters.

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) Historical Current Ratio (quarterly & annually)

How has 605199.SS Current Ratio performed in the past?

The mean historical Current Ratio of Hainan Huluwa Pharmaceutical Group Co., Ltd. over the last ten years is 1.22. The current 0.82 Current Ratio has changed 6.65% with respect to the historical average. Over the past ten years (40 quarters), 605199.SS's Current Ratio was at its highest in in the June 2021 quarter at 2.22. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hainan Huluwa Pharmaceutical Group Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) Average Current Ratio

How has 605199.SS Current Ratio performed in the past?

The current Current Ratio of Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) Current Ratio vs. Peers

How is 605199.SS’s Current Ratio compared to its peers?

Hainan Huluwa Pharmaceutical Group Co., Ltd.’s Current Ratio is less than Zhejiang Wecome Pharmaceutical Company Limited (2.34), less than Baolingbao Biology Co.,Ltd. (1.83), less than Shanghai ZJ Bio-Tech Co., Ltd. (23.06), less than Shanghai Model Organisms Center, Inc. (7.48), greater than Lifecome Biochemistry Co.,Ltd. (0.15), less than Qingdao Vland Biotech Inc. (1.08), less than Yantai Zhenghai Biotechnology Co., Ltd. (8.89), less than Cabio Biotech (Wuhan) Co., Ltd. (5.79), less than Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (3.82), less than Guangdong Hybribio Biotech Co.,Ltd. (5.06),

Build a custom stock screener for Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hainan Huluwa Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hainan Huluwa Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.